Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.30 |
| ▸ | MMP9 | P14780 | 1/20 | 0.30 |
| ▸ | MMP8 | P22894 | 1/20 | 0.30 |
| ▸ | MMP14 | P50281 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13791328 | 0.87 | THRB (0.38) | MEN1KMT2ATHRB | |
| SCHEMBL13791369 | 0.83 | ZDHHC20 (0.38) | MEN1KMT2AHSD17B10 | |
| SCHEMBL13791399 | 0.82 | THRB (0.51) | HSD17B10THRB | |
| SCHEMBL13791411 | 0.80 | LMNA (0.39) | — | |
| SCHEMBL10051130 | 0.78 | USP2 (0.42) | MEN1KMT2ATHRBMMP9MMP8 | |
| SCHEMBL3770023 | 0.77 | BBOX1 (0.37) | KMT2A | |
| SCHEMBL17309572 | 0.77 | MMP9 (0.34) | KMT2AMMP9MMP8MMP14 | |
| SCHEMBL10051131 | 0.76 | MEN1 (0.36) | MEN1KMT2AHSD17B10THRBMMP9 | |
| SCHEMBL3764634 | 0.75 | BBOX1 (0.43) | MEN1KMT2A | |
| SCHEMBL13791382 | 0.74 | TSHR (0.49) | HSD17B10THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7553881-B2 | Dental materials based on radically polymerizable macromers with antimicrobial effect | IVOCLAR VIVADENT AG (LI) | 2009-06-30 | — | — | US | disclosed |
| US-20070254979-A1 | Dental materials based on radically polymerizable macromers with antimicrobial effect | IVOCLAR VIVADENT AG (LI) | 2007-11-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070254979-A1 | Dental materials based on radically polymerizable macromers with antimicrobial effect | MSR1, PAM, C1R | MEN1 2242/4885KMT2A 3440/4885HSD17B10 2274/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.